0001127602-21-027342.txt : 20211019
0001127602-21-027342.hdr.sgml : 20211019
20211019162149
ACCESSION NUMBER: 0001127602-21-027342
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211015
FILED AS OF DATE: 20211019
DATE AS OF CHANGE: 20211019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hutson Nancy J
CENTRAL INDEX KEY: 0001379222
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-23186
FILM NUMBER: 211331347
MAIL ADDRESS:
STREET 1: 64 MONTAUK AVENUE
CITY: STONINGTON
STATE: CT
ZIP: 06378
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000882796
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621413174
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-859-1302
MAIL ADDRESS:
STREET 1: 4505 EMPEROR BOULEVARD
STREET 2: SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-10-15
0000882796
BIOCRYST PHARMACEUTICALS INC
BCRX
0001379222
Hutson Nancy J
64 MONTAUK AVENUE
STONINGTON
CT
06378
1
Common Stock
2021-10-15
4
M
0
30000
2.91
A
95073
D
Common Stock
2021-10-15
4
M
0
30000
5.13
A
125073
D
Common Stock
2021-10-15
4
M
0
15000
1.71
A
140073
D
Common Stock
2021-10-15
4
M
0
30000
3.22
A
170073
D
Common Stock
2021-10-15
4
S
0
105000
15.40
D
65073
D
Automatic Stock Option Grant
2.91
2021-10-15
4
M
0
30000
0
D
2020-05-29
2029-05-29
Common Stock
30000
0
D
Automatic Stock Option Grant
5.13
2021-10-15
4
M
0
30000
0
D
2017-06-24
2027-05-24
Common Stock
30000
0
D
Automatic Stock Option Grant
1.71
2021-10-15
4
M
0
15000
0
D
2013-06-30
2023-05-31
Common Stock
15000
0
D
Automatic Stock Option Grant
3.22
2021-10-15
4
M
0
30000
0
D
2016-06-23
2026-05-23
Common Stock
30000
0
D
This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2021.
The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $15.13 to $15.51. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote.
/s/ Alane P. Barnes, by power of attorney
2021-10-19